<DOC>
	<DOC>NCT00033046</DOC>
	<brief_summary>The purpose of this study is to evaluate modafinil, a cocaine treatment medication, and its interactions with intravenous (IV) cocaine.</brief_summary>
	<brief_title>Evaluation of Modafinil as a Cocaine Treatment Medication and Interactions With Cocaine - 1</brief_title>
	<detailed_description>Placebo-controlled, escalating dose drug interaction study using a total of 12 cocaine users at a single site. Study duration will include four infusion sessions: 1) screening/baseline; 2) baseline; 3) 400mg/day steady-state modafinil; 4) 800 mg/day steady state modafinil. Infusion session will be 2 days in duration.</detailed_description>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>Dependent on cocaine; nontreatment seeking; male or female; DSM4 criteria for cocaine abuse or dependence; at least 18 years of age but no older than 45 nonpregnant females using adequate birth control; capable of providing written informed consent; able to comply with protocol requirements. Additional criteria available during screening at the site</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2004</verification_date>
</DOC>